The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Borenshteĭn A.I.

Kafedra fakul'tetskoĭ khirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova, Gorodskaia klinicheskaia bol'nitsa #1 im. N.I. Pirogova, Moskva

Mironova E.N.

Kafedra fakul'tetskoĭ khirurgii lechebnogo fakul'teta Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Andryashkin A.V.

Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia

Zolotukhin I.A.

Pirogov Russian National Research Medical University, Moscow, Russia

Prevention of venous thromboembolism after phlebectomy

Authors:

Borenshteĭn A.I., Mironova E.N., Andryashkin A.V., Zolotukhin I.A.

More about the authors

Journal: Journal of Venous Disorders. 2012;6(4): 29‑34

Read: 5413 times


To cite this article:

Borenshteĭn AI, Mironova EN, Andryashkin AV, Zolotukhin IA. Prevention of venous thromboembolism after phlebectomy. Journal of Venous Disorders. 2012;6(4):29‑34. (In Russ.)

Recommended articles:
Ranking of mechanical thro­mboprophylaxis methods in surgery: a network meta-analysis. Medi­cal Technologies. Asse­ssment and Choice. 2026;(1):143-152

References:

  1. Hirsh J., Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals from the Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996; 93: 2212-2245.
  2. Anderson F.A., Wheeler H.B, Goldberg R.J., Hosmer D.W., Patwardhan N.A., Jovanovic B., ForcierA, Dalen J.E. A populationbased perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.
  3. Sigler L., Romero T., Meillón L.A., Gutiérrez L., Aguirre G.J., Esparza C. Tromboembolia pulmonar en un período de 10 años. Rev Med IMSS 1996; 34: 7-11.
  4. Sandoval Z.J., Martínez G.M.L., Gómez A., Palomar A., Pulido T., Zevallos M. PAC Cardio-1. Tromboembolia pulmonar aguda. Sociedad Mexicana de Cardiología. Mexico: Editorial Intersistemas 1998; 7-9.
  5. Nijsten T., van den Bos R., Goldman M., Kockaert M., Proebstle T., Rabe E. Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol 2009; 60: 1: 110-119.
  6. Dimick J.B., Chen S.L., Taheri P.A., Henderson W.G., Khuri S.F., Camp­bell D.A.Jr. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg 2004; 199: 531-537.
  7. White R.H., Zhou H., Romano P.S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thrombos Haemost 2003, 90: 3: 446-455.
  8. Rossiiskie klinicheskie rekomendatsii po diagnostike, lecheniyu i profilaktike venoznykh tromboembolicheskikh oslozhnenii. M 2010; 31.
  9. Lonnie L. Whiddon Advances in the treatment of superficial venous insufficiency of the lower extremities. Proc (Bayl Univ Med Cent) 2007; 20: 136-139.
  10. Kalra M., Gloviczki P. Endovenous Ablation of the Saphenous Vein. Perspectiv Vscul Surg Endovascul Ther 2008; 20: 4: 371-380.
  11. Mills E.J., Nachega J.B., Buchan I., Orbinski J., Attaran A.,Singh S., Rachlis B., Wu P., Cooper C., Thabane L., Wilson K., Guyatt G.H., Bangsberg D.R. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006; 296: 6: 679-690.
  12. van Rij A.M., Chai J., Hill G.B., Christie R.A. Incidence of deep vein thrombosis after varicose vein surgery. Br J Surg 2004; 91: 1582-1585.
  13. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., Melton L.J.III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-815.
  14. Nicolaides A.N., Irving D. Clinical factors and the risk of deep venous thrombosis. In: Thromboembolism Etiology. Ed. A. Nicolaides. Advances in Prevention and Management. Baltimore: University Park Press 1975; 193-204.
  15. Gjores J.E. The incidence of venous thrombosis and its sequelae in certain districts in Sweden. Acta Chir Scand 1993; 111: Suppl 206: 16-24.
  16. Emery J.L. Pulmonary embolism in children. Arch Dis Child 1962; 37: 591-595.
  17. Kakkar V., Howe C., Nicolaides A., Renney J., Clarke M. Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg 1970; 120: 527-530.
  18. Printen K.J., Miller E.V., Mason E.E., Barnes R.W. Venous thromboembolism in the morbidly obese. Surg Gynecol Obstet 1978; 147: 63-64.
  19. Warlow C. Venous thromboembolism after stroke. Am Heart J 1978; 96: 3: 283-285.
  20. Lidegaard O., Edstrom B., Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception 2002; 65: 187-196.
  21. Grady D., Applegate W., Bush T. Heart and Estrogen/progestinReplacement Study (HERS): design, methods, and baseline characteristics. Control Clin Trials 1998; 19: 314-335.
  22. Grodstein F., Stampfer M.J., Goldhaber S.Z., Manson J.E., Colditz G.A., Speizer F.E., Willett W.C., Hennekens C.H. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-987.
  23. Daly E., Vessey M.P., Hawkins M.M., Carson J.L., Gough P., Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-980.
  24. Varas-Lorenzo C., Alberto L., Chiara G-R., Cattaruzzi M., Troncon G., Agostinis L., Perez-Gutthann S. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe. Am J Epidemiol 1998; 147: 387-390.
  25. Lowe G., Woodward M., Vessey M., Rumley A., Gough P., Daly E. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy. Thromb Haemost 2000; 83: 530-535.
  26. Zaichik A.Sh., Churilov L.P. Mekhanizmy razvitiya boleznei i sindromov. SPb ELBI 2002; 455-459.
  27. Samama M.M. Epidemiology of risk factors of deep venous thrombosis (DVT) of the lower limbs in community practice: the SIRIUS study. Thromb Haemost 1993; 69: 763.
  28. Edmonds M.J.R., Crichton T.J.H., Runciman W.B., Pradhan M. Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J Surg 2004; 74: 12: 1082-1097.
  29. Rocha A.T., Paiva E.F., Lichtenstein A., Milani J., Cavalheiro-Filho C., Maffei F.H. Riskassessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag 2007; 3: 4: 533-553.
  30. Critchley G., Handa A., Maw A., Harvey A., Harvey M.R., Corbett C.R. Complications of varicose vein surgery. Ann R Coll Surg Engl 1997; 79: 105-110.
  31. Pleister I. Natural History of the Great Saphenous Vein Stump Following Endovenous Laser Therapy Columbus Surgical Society, 19th Annual Presidential Symposium, Columbus (Ohio) 2008; 16.
  32. Hingorani A.P., Ascher E., Markevich N. Deep venous thrombosis after radiofrequency ablation of greater saphenous vein: A word of caution. J Vasc Surg 2004; 40: 500-504.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.